Comerica Bank lifted its position in shares of Relx Plc (NYSE:RELX – Get Rating) by 4.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 37,992 shares of the technology company’s stock after acquiring an additional 1,614 shares during the quarter. Comerica Bank’s holdings in Relx were worth $975,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in RELX. CoreCap Advisors LLC bought a new stake in shares of Relx during the second quarter worth $28,000. Allworth Financial LP raised its position in shares of Relx by 455.3% during the third quarter. Allworth Financial LP now owns 1,455 shares of the technology company’s stock worth $35,000 after acquiring an additional 1,193 shares during the last quarter. Pinnacle Bancorp Inc. bought a new stake in shares of Relx during the third quarter worth $35,000. Wipfli Financial Advisors LLC bought a new stake in shares of Relx during the third quarter worth $42,000. Finally, American National Bank bought a new stake in shares of Relx during the third quarter worth $51,000. Institutional investors own 3.41% of the company’s stock.
Relx Stock Down 0.4 %
NYSE:RELX opened at $29.35 on Wednesday. Relx Plc has a 1 year low of $23.39 and a 1 year high of $32.24. The company has a debt-to-equity ratio of 1.64, a current ratio of 0.51 and a quick ratio of 0.45. The stock has a 50-day moving average price of $28.27 and a two-hundred day moving average price of $27.25.
Wall Street Analyst Weigh In
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.
- Get a free copy of the StockNews.com research report on Relx (RELX)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.